ImetelChat

BP and all the rest of the regulars here, thank you. Thank you for so generously sharing your abject wisdom as well as all the information you dig up. Thank you for your patience with those of us who visit this board in search of information. Thank you for weeding out the bashers and blowhards who p...

Couldn’t agree with you more BP.

It’s curious though why he and 4 out of 5 high level execs chose to cash in all those options in February. It sure sent the wrong message to the market.

Time will tell.

A very shiny apple indeed BP. Here is a reminder of Dr Scarlett’s resume prior to joining Geron. MENLO PARK, Calif., September 29, 2011 - Geron Corporation (Nasdaq: GERN) announced today that its board of directors has appointed John A. Scarlett, M.D. as its Chief Executive Officer and to its board ...

Two more weeks for notification of priority review and PDUFA In layman’s terms what exactly does this mean? https://ir.geron.com/investors/press-releases/press-release-details/2023/Geron-Announces-FDA-Acceptance-of-New-Drug-Application-for-Imetelstat-for-the-Treatment-of-Lower-Risk-MDS/default.aspx

Thank you biopearl, kmall, and everyone else on this board who over the years has contributed so much. I have watched, read, and learned so much from you all!! Having been onboard since the old days of stem cells it’s been a challenging and long ride navigating disappointment over and over again. I’...

I'm hoping one of you may be able to answer me. First of all has JnJ filed an NDA based on either of these 2 clinical trials Imerge or Imbark? I know there has been speculation about this happening. And I have looked for past CTs especially in cancer therapies where an NDA has been filed based on ph...